Simon Sharon - 22 Feb 2024 Form 4 Insider Report for Microbot Medical Inc. (MBOT)

Role: General Manager, CTO
Signature: /s/ Simon Sharon
Issuer symbol: MBOT
Transactions as of: 22 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 26 Feb 2024, 18:41:14 UTC
Previous filing: 03 Aug 2023
Next filing: 07 Feb 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MBOT	Stock Option (Right to Buy)	Award	$0	+17,500		$0.000000	17,500	22 Feb 2024	Common Stock, par value $0.01 per share	17,500	$1.27	Direct	F1
transaction	MBOT	Stock Option (Right to Buy)	Award	$0	+17,500		$0.000000	17,500	22 Feb 2024	Common Stock, par value $0.01 per share	17,500	$1.27	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

Content

The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.